Wang Zhengfeng, He Ru, Dong Shi, Zhou Wence
Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China.
The Second School of Clinical Medicine, Lanzhou University Medical College, Lanzhou, China.
Front Oncol. 2023 Jun 20;13:1185093. doi: 10.3389/fonc.2023.1185093. eCollection 2023.
Pancreatic cancer is a strongly malignant gastrointestinal carcinoma characterized by late detection, high mortality rates, poor patient prognosis and lack of effective treatments. Consequently, there is an urgent need to identify novel therapeutic strategies for this disease. Pancreatic stellate cells, which constitute a significant component of the mesenchymal cellular layer within the pancreatic tumor microenvironment, play a pivotal role in modulating this environment through their interactions with pancreatic cancer cells. This paper reviews the mechanisms by which pancreatic stellate cells inhibit antitumor immune responses and promote cancer progression. We also discuss preclinical studies focusing on these cells, with the goal of providing some theoretical references for the development of new therapeutic approaches for pancreatic cancer.
胰腺癌是一种恶性程度很高的胃肠道癌,其特点是发现晚、死亡率高、患者预后差且缺乏有效治疗方法。因此,迫切需要为这种疾病确定新的治疗策略。胰腺星状细胞是胰腺肿瘤微环境中间充质细胞层的重要组成部分,通过与胰腺癌细胞相互作用,在调节这一环境中发挥关键作用。本文综述了胰腺星状细胞抑制抗肿瘤免疫反应和促进癌症进展的机制。我们还讨论了针对这些细胞的临床前研究,旨在为开发胰腺癌新治疗方法提供一些理论参考。